ORCHESTRA BIOMED HOLDINGS INC. - ORDINARY SHARES

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

29 أبريل 2025 09:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

28 أبريل 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

23 أبريل 2025 09:00:13 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

22 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

31 مارس 2025 16:21:30 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Present at Upcoming Investor Conferences

20 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

18 فبراير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12 فبراير 2025 10:43:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

05 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

09 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

26 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

12 نوفمبر 2024 16:12:39 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

07 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

12 أغسطس 2024 16:20:20 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

30 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

04 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

22 مايو 2024 08:43:18 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

13 مايو 2024 16:58:13 بحسب Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

30 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

30 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire